HealthEquity Current Ratio 2014-2024 | HQY
Current and historical current ratio for HealthEquity (HQY) from 2014 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. HealthEquity current ratio for the three months ending October 31, 2024 was 3.21.
| HealthEquity Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-10-31 | $0.50B | $0.16B | 3.21 |
| 2024-07-31 | $0.50B | $0.12B | 4.10 |
| 2024-04-30 | $0.41B | $0.09B | 4.39 |
| 2024-01-31 | $0.56B | $0.12B | 4.76 |
| 2023-10-31 | $0.47B | $0.10B | 4.93 |
| 2023-07-31 | $0.42B | $0.10B | 4.09 |
| 2023-04-30 | $0.36B | $0.09B | 4.00 |
| 2023-01-31 | $0.38B | $0.13B | 2.92 |
| 2022-10-31 | $0.33B | $0.11B | 3.01 |
| 2022-07-31 | $0.31B | $0.13B | 2.46 |
| 2022-04-30 | $0.28B | $0.12B | 2.37 |
| 2022-01-31 | $0.35B | $0.15B | 2.29 |
| 2021-10-31 | $0.76B | $0.11B | 7.14 |
| 2021-07-31 | $0.86B | $0.19B | 4.65 |
| 2021-04-30 | $0.87B | $0.19B | 4.50 |
| 2021-01-31 | $0.46B | $0.21B | 2.25 |
| 2020-10-31 | $0.40B | $0.15B | 2.62 |
| 2020-07-31 | $0.38B | $0.15B | 2.49 |
| 2020-04-30 | $0.28B | $0.14B | 2.11 |
| 2020-01-31 | $0.30B | $0.15B | 1.96 |
| 2019-10-31 | $0.27B | $0.14B | 1.91 |
| 2019-07-31 | $0.85B | $0.04B | 22.98 |
| 2019-04-30 | $0.37B | $0.02B | 15.60 |
| 2019-01-31 | $0.40B | $0.03B | 13.59 |
| 2018-10-31 | $0.36B | $0.02B | 20.91 |
| 2018-07-31 | $0.34B | $0.02B | 19.90 |
| 2018-04-30 | $0.30B | $0.02B | 17.71 |
| 2018-01-31 | $0.27B | $0.02B | 12.95 |
| 2017-10-31 | $0.25B | $0.02B | 12.98 |
| 2017-07-31 | $0.24B | $0.01B | 18.51 |
| 2017-04-30 | $0.22B | $0.01B | 21.27 |
| 2017-01-31 | $0.20B | $0.02B | 12.79 |
| 2016-10-31 | $0.19B | $0.01B | 17.83 |
| 2016-07-31 | $0.17B | $0.01B | 19.44 |
| 2016-04-30 | $0.16B | $0.01B | 22.30 |
| 2016-01-31 | $0.14B | $0.01B | 11.82 |
| 2015-10-31 | $0.14B | $0.01B | 15.08 |
| 2015-07-31 | $0.17B | $0.01B | 23.32 |
| 2015-04-30 | $0.13B | $0.01B | 25.13 |
| 2015-01-31 | $0.13B | $0.01B | 14.12 |
| 2014-10-31 | $0.12B | $0.01B | 18.76 |
| 2014-07-31 | $0.03B | $0.01B | 4.74 |
| 2014-04-30 | $0.00B | 0.00 | |
| 2014-01-31 | $0.00B | 0.00 | |
| 2013-10-31 | $0.00B | 0.00 | |
| 2013-07-31 | $0.00B | 0.00 | |
| 2013-01-31 | $0.02B | $0.01B | 1.85 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.876B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $89.358B | 11.09 |
| Cencora (COR) | United States | $46.783B | 17.59 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Natera (NTRA) | United States | $20.907B | 0.00 |
| ICON (ICLR) | Ireland | $16.343B | 14.56 |
| Avantor (AVTR) | United States | $15.048B | 22.56 |
| Revvity (RVTY) | United States | $14.408B | 25.03 |
| BioMerieux (BMXMF) | France | $13.788B | 0.00 |
| Viatris (VTRS) | United States | $13.488B | 4.15 |
| Solventum (SOLV) | United States | $12.699B | 0.00 |
| CochLear (CHEOY) | Australia | $12.341B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.485B | 29.54 |
| Doximity (DOCS) | United States | $10.029B | 59.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.551B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.361B | 16.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.244B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.118B | 28.46 |
| Organon (OGN) | United States | $4.054B | 4.09 |
| Sotera Health (SHC) | United States | $3.676B | 19.67 |
| BrightSpring Health Services (BTSG) | United States | $3.230B | 68.70 |
| Alignment Healthcare (ALHC) | United States | $2.795B | 0.00 |
| Concentras Parent (CON) | United States | $2.691B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.566B | 29.26 |
| Premier (PINC) | United States | $2.156B | 11.22 |
| PACS (PACS) | United States | $2.106B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.013B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.909B | 0.00 |
| Progyny (PGNY) | United States | $1.788B | 36.21 |
| GoodRx Holdings (GDRX) | United States | $1.742B | 45.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.565B | 0.00 |
| Agilon Health (AGL) | United States | $1.273B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.189B | 11.63 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| Embecta (EMBC) | United States | $1.086B | 7.59 |
| AMN Healthcare Services Inc (AMN) | United States | $0.986B | 6.67 |
| Establishment Labs Holdings (ESTA) | $0.968B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.624B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.429B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
| DocGo (DCGO) | United States | $0.426B | 16.04 |
| Enhabit (EHAB) | United States | $0.402B | 34.74 |
| MultiPlan (MPLN) | United States | $0.260B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.239B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Beauty Health (SKIN) | United States | $0.216B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Nutex Health (NUTX) | United States | $0.206B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.167B | 0.00 |
| So-Young (SY) | China | $0.110B | 18.60 |
| ModivCare (MODV) | United States | $0.093B | 5.03 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.63 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| Oncology Institute (TOI) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |